Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.61 |
| ▸ | CA12 | O43570 | 3/20 | 0.61 |
| ▸ | CA1 | P00915 | 3/20 | 0.61 |
| ▸ | CA2 | P00918 | 3/20 | 0.61 |
| ▸ | CA7 | P43166 | 3/20 | 0.61 |
| ▸ | CA9 | Q16790 | 3/20 | 0.61 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.57 |
| ▸ | MAPT | P10636 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.57 |
| ▸ | HNF4A | P41235 | 1/20 | 0.53 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.53 |
| ▸ | HPGD | P15428 | 4/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | GRM1 | Q13255 | 2/20 | 0.48 |
| ▸ | GRM2 | Q14416 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetamide SCHEMBL7251208 | 0.90 | ALDH1A1 (0.53) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL28789444 | 0.83 | ALDH1A1 (0.58) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL129664 | 0.82 | CA1 (0.61) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL29662013 | 0.82 | CA1 (0.61) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL522679 | 0.81 | PTPN1 (0.55) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL15270445 | 0.80 | CES2 (0.45) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL11458189 | 0.80 | ERN1 (0.41) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL3341120 | 0.80 | ALDH1A1 (0.55) | ALDH1A1KDM4EMAPTCYP3A4GAA | |
| SCHEMBL31396647 | 0.80 | ALDH1A1 (0.50) | ALDH1A1CA12CA1CA2CA7 | |
| SCHEMBL24407738 | 0.79 | ALDH1A1 (0.48) | ALDH1A1CA12CA1CA2CA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119751377-A | Synthesis method of 2- (benzothiazole-2-yl) -5- (hex-1-yne-1-yl) phenol | 南京恒贝新材料有限公司 | 2025-04-04 | — | — | CN | claimed |
| CN-112079712-B | Preparation method of p-vinyl salicylic acid | 江苏美迪克化学品有限公司 | 2022-12-13 | — | — | CN | claimed |
| CN-112079712-A | Preparation method of p-vinyl salicylic acid | 江苏美迪克化学品有限公司 | 2020-12-15 | — | — | CN | claimed |
| CN-104070307-B | Solder flux composition and solder composition | 株式会社田村制作所 | 2018-02-23 | — | — | CN | claimed |
| US-20250289780-A1 | N,N'-DIPHENYL-4,4'-BIPHENYLDICARBOXAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2025-09-18 | — | — | US | disclosed |
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | KAO CORPORATION (JP) | 2025-07-03 | — | — | US | disclosed |
| WO-2025124618-A1 | DESIGN, PREPARATION AND APPLICATION OF TARGETED ACTIVATION ENRICHMENT TYPE NEAR-INFRARED PROBE AND PHOTOSENSITIZER | 华东理工大学 | 2025-06-19 | — | — | WO | disclosed |
| CN-120136922-A | Design, preparation and application of targeted activation enrichment near infrared probe and photosensitizer | 华东理工大学 | 2025-06-13 | — | — | CN | disclosed |
| CN-119751377-A | Synthesis method of 2- (benzothiazole-2-yl) -5- (hex-1-yne-1-yl) phenol | 南京恒贝新材料有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119751377-A | Synthesis method of 2- (benzothiazole-2-yl) -5- (hex-1-yne-1-yl) phenol | 南京恒贝新材料有限公司 | 2025-04-04 | — | — | CN | disclosed |
| US-20250041408-A1 | SMALL MOLECULE IMMUNOPOTENTIATOR CONJUGATES OF NFKB ACTIVATORS AS ADJUVANTS WITH ENHANCED EFFICACY AND REDUCED TOXICITY | THE UNIVERSITY OF CHICAGO | 2025-02-06 | — | — | US | disclosed |
| EP-4501896-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | Kao Corporation (JP) | 2025-02-05 | — | — | EP | disclosed |
| WO-1995013262-A1 | SUBSTITUTED PHENYL COMPOUNDS | RHONE-POULENC RORER LIMITED (GB) | 1995-05-18 | — | — | WO | disclosed |
| US-5358948-A | Psychological, nervous system disorders | GLAXCO GROUP LIMITED (GB) | 1994-10-25 | — | — | US | disclosed |
| US-5244771-A | Bridged indicator dyes used as light-absorbing, pH-sensitive optical filter agents in diffusion transfer | POLAROID CORPORATION (US) | 1993-09-14 | — | — | US | disclosed |
| EP-0553346-A1 | PHOTOGRAPHIC PRODUCTS AND PROCESSES | POLAROID CORPORATION (US) | 1993-08-04 | — | — | EP | disclosed |
| CN-1073430-A | Benzanilide derivatives | GLAXO GROUP LTD (GB) | 1993-06-23 | — | — | CN | disclosed |
| WO-1993006084-A1 | BENZANILIDE DERIVATIVES AS 5-HT1D ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1993-04-01 | — | — | WO | disclosed |
| EP-0533267-A1 | Benzanilide derivatives as 5-HT1D antagonists | GLAXO GROUP LIMITED (GB) | 1993-03-24 | — | — | EP | disclosed |
| WO-1993004403-A1 | PHOTOGRAPHIC PRODUCTS AND PROCESSES | POLAROID CORPORATION (US) | 1993-03-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250214920-A1 | METHOD FOR PRODUCING CYCLIC DIKETONE COMPOUND | CYP4F2, DUOX1, BCKDK | ALDH1A1 973/4885CA12 1156/4885CA1 1048/4885 |
| US-20250289780-A1 | N,N'-DIPHENYL-4,4'-BIPHENYLDICARBOXAMIDE ANALOGS AND THEIR USE IN CANCER TREATMENT | NCOR1, NR1H4, NR1I2 | ALDH1A1 2644/4885CA12 2884/4885CA1 2457/4885 |
| US-20250041408-A1 | SMALL MOLECULE IMMUNOPOTENTIATOR CONJUGATES OF NFKB ACTIVATORS AS ADJUVANTS WITH ENHANCED EFFICACY AND REDUCED TOXICITY | NFKBIA, NFRKB, NFKB2 | ALDH1A1 4393/4885CA12 3791/4885CA1 4344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.